期刊文献+

CD28/B7在银屑病皮损及外周血淋巴细胞中的表达 被引量:5

Expression of CD28/B7 in the Lesional Skin and Peripheral Lymphocytes in Psoriasis
原文传递
导出
摘要 目的探讨CD28/B7共同刺激分子在银屑病发病中的作用。方法采用免疫组化ABC法检测22例银屑病皮损、流式细胞仪检测17例银屑病外周血淋巴细胞CD28、CD80、CD86的表达水平。15例整形外科手术患者的皮肤和外周血作为正常人对照。结果免疫组化结果显示银屑病组皮损中CD28、CD80、CD86的表达明显增多,与正常人对照组相比差异均有显著性(P<0.01);进行期皮损中的表达显著高于静止期,差异均有显著性(P<0.05)。流式细胞仪检测显示CD28、CD80、CD86在银屑病组外周血淋巴细胞中的表达明显高于对照组,差异有显著性(P<0.01);进行期组与静止期组相比,CD28差异无显著性(P>0.05),CD80与CD86差异有显著性(P1<0.01,P2<0.05)。结论CD28、CD80、CD86在银屑病发展过程中起一定作用。 Objective To investigate the role of costimulatory molecules CD28/B7 in the pathogenesis of psoriasis. Methods The expression of CD28, CD80 and CD86 was detected in the lesional skin of 22 cases by immunohistochemical technique (ABC), and in the peripheral blood lymphocytes of 17 cases by flow cytometry respectively. As control, normal skin and lymphocytes from peripheral blood of healthy volunteers were also tested. Results The immunohistochemistry study showed that the expression of CD28, CD80 and CD86 in the psoriatic lesions was significantly higher than that in the normal controls (P < 0.01). Comparing with the lesions of stable stage the expression was higher in the lesions progressive stage (P < 0.05). According to the results of flow cytometry, the expression of CD28, CD80 and CD86 on the lymphocytes of psoriasis was significantly higher than that in the normal controls (P < 0.01); comparing the lesions of two stages significantly higher expression of CD80 and CD86 was found in the lesions of progressive stage respectively (P < 0.01, P < 0.05), but no difference for CD28 (P >.05). Conclusion CD28, CD80 and CD86 might play a certain role in the pathogenesis in psoriasis.
出处 《中华皮肤科杂志》 CAS CSCD 北大核心 2004年第10期589-591,共3页 Chinese Journal of Dermatology
基金 湖北省科技攻关计划(2001AA308B23)
关键词 CD28 CD86 CD80 银屑病皮损 外周血淋巴细胞 表达 对照组 显著性 Psoriasis Antigens, CD28 Antigens, CD80 Antigens, CD86
  • 相关文献

参考文献9

  • 1Garcia RL, Coltrera MD, Gown AM.Analysis of proliferative grade using anti-PCNA/cyclin monoclonal antibodies in fixed, embedded tissues. Comparison with flow cytometric analysis. Am J Pathol,1989, 134:733-739.
  • 2Ferenczi K, Burack L, Pope M, et al. CD69, HLA-DR and the IL-2R identify persistently activated T cells in psoriasis vulgaris lesional skin: blood and skin comparisons by flow cytometry. J Autoimmun, 2000, 14:63-78.
  • 3Nickoloff B J, Nestle FO, Zheng XG, et al. T lymphocytes in skin lesions of psoriasis and mycosis fungoides express B7-1: a ligand for CD28.Blood, 1994, 83:2580-2586.
  • 4朱可建,周伟芳,劳力民,郑敏.银屑病患者外周血单核细胞向树突状细胞分化能力的研究[J].中华皮肤科杂志,2002,35(2):88-90. 被引量:6
  • 5Geissmann F, Prost C, Monnet JP, et al. Transforming growth factor betal, in the presence of granulocyte/macrophage colony-stimulating factor and interleukin 4, induces differentiation of human peripheral blood monocytes into dendritic Langerhans cells. J Exp Med,1998, 187:961-966.
  • 6Yu Y, Tang L, Wang J, et al. Psoriatic lesional keratinocytes promote the maturation of human monocyte-derived Langerhans cells.Dermatology, 2002, 204: 94-99.
  • 7Zhu K, Mrowietz U. Inhibition of dendritic cell differentiation by fumaric acid esters.J Invest Dermatol, 2001, 116:203-208.
  • 8Gottlieb AB, Lebwohl M, Totoritis MC, et al. Clinical and histologic response to single-dose treatment of moderate to severe psoriasis with an anti-CD80 monoclonal antibody. J Am Acad Dermatol,2002, 47: 692-700.
  • 9Abrams JR, Kelley SL, Hayes E, et al. Blockade of T lymphocyte costimulation with cytotoxic T lymphocyte-associated antigen 4-immunoglobulin (CTLA4Ig) reverses the cellular pathology of psoriatic plaques, including the activation of keratinocytes, dendritic cells,and endothelial cells. J Exp Med, 2000, 192:681-694.

二级参考文献9

  • 1Nestle FO, Turka LA, Nickoloff BJ. Characterization of dermal dendritic cells in psoriasis. Autostimulation of T lymphocytes and induction of Th1 type cytokines. J Clin Invest, 1994,94:202- 209.
  • 2Dam TN, Moller B, Hindkjaer J, et al. The vitamin D3 analog calcipotriol suppresses the number and antigen- presenting function of Langerhans cells in normal human skin. J Investig Dermatol Symp Proc, 1996,1:72- 77.
  • 3Zhu K, Mrowietz U. Inhibition of dendritic cell differentiation by fumaric acid esters. J Invest Dermatol, 2001,116:203- 208.
  • 4Cooper KD, Baadsgaard O, Ellis CN, et al. Mechanisms of cyclosporin A inhibition of antigen- presenting activity in uninvolved and lesional psoriatic epidermis. J Invest Dermatol, 1990, 94: 649- 656.
  • 5Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony- stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med, 1994,179:1109- 1118.
  • 6Valdimarsson H, Sigmundsdottir H, Jonsdottir I. Is psoriasis induced by streptococcal superantigens and maintained by M- protein- specific T cells that cross- react with keratin? Clin Exp Immunol, 1997,107(Suppl 1):21- 24.
  • 7Drakesmith H, Chain B, Beverley P. How can dendritic cells cause autoimmune disease? Immunol Today, 2000,21:214- 217.
  • 8Geissmann F, Prost C, Monnet JP, et al. Transforming growth factor beta 1, in the presence of granulocyte/macrophage colony- stimulating factor and interleukin 4, induces differentiation of human peripheral blood monocytes into dendritic Langerhans cells. J Exp Med, 1998,187:961- 966.
  • 9Asadullah K, Sterry W, Stephanek K, et al. IL- 10 is a key cytokine in psoriasis. Proof of principle by IL- 10 therapy: a new therapeutic approach. J Clin Invest, 1998,101:783- 794.

共引文献5

同被引文献37

  • 1李圆圆,王玉坤.B7-CD28/CTLA-4在银屑病的研究进展[J].国外医学(皮肤性病学分册),2005,31(2):102-104. 被引量:1
  • 2张开明,徐海涛,李新华.外周血细胞与银屑病[J].临床皮肤科杂志,2005,34(9):636-638. 被引量:2
  • 3王刚,刘玉峰.银屑病患者外周血单一核细胞对自身角朊细胞的促生长作用[J].中华皮肤科杂志,1996,29(2):111-112. 被引量:3
  • 4Schmitz I, Weyd H, Krueger A, et al. Resistance of short term activated T cells to CD95-mediated apoptosis correlates with de novo protein synthesis of c-FLIPshort. J Immunol, 2004, 172 (4): 2194-2200.
  • 5Krueger JG. The immunologic basis for the treatment of psoriasis with new biologic agents. J Am Acad Dermatol, 2002, 46( 1): 1-23.
  • 6Lebwohl M. Psoriasis. Lancet, 2003, 361(9364): 1197-1204.
  • 7Nickoloff BJ, Nestle FO. Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities. J Clin Invest, 2004, 113( 12): 1664-1675.
  • 8Bowcock AM, Krueger JG. Getting under the skin: the immunogenetics of psoriasis. Nat Rev Immunol, 2005, 5(9): 699-711.
  • 9Schon MP, Boehncke WH. Psoriasis. N Engl J Med, 2005, 352 ( 18): 1899-1912.
  • 10Gaspari AA. Innate and adaptive immunity and the pathophysiology of psoriasis. J Am Acad Dermatol, 2006, 54 (3 Suppl 2): S67-S80.

引证文献5

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部